Skip to main content
Clinical Trials/NL-OMON50274
NL-OMON50274RecruitingNot Applicable

The Effect of Leukocyte DNA mEthylation and micRoBIOME diversity and function on host defense mechanisms during community-acquired pneumonia. - ELDER-BIOME study

Academisch Medisch Centrum0 sites843 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
843

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1) Age >= 18 y
  • 2) Clinical suspicion of a new episode of acute respiratory tract infection
  • 3) The presence of a new or increased infiltrate on chest radiography or
  • computed tomography (CT) or a positive SARS-CoV-2 PCR on nasopharyngeal swab
  • within 14 days prior to admission
  • 4) Presence of two or more diagnostic clinical criteria:
  • - Production of purulent sputum or a change in the character of sputum
  • - Temperature >38°C or <36.1°C
  • - Auscultatory findings consistent with pneumonia, including rales,
  • evidence of pulmonary consolidation (dullness on percussion, bronchial breath
  • sounds, or egophony), or both
  • - Leukocytosis (>10×109 white cells per liter or >15% bands)
  • - C-reactive protein level of more than 3 times the upper limit of the
  • normal range
  • - Dyspnea, tachypnea, or hypoxemia

Exclusion Criteria

  • 1) No informed consent is provided by patient
  • 2) Patients who had recently been hospitalized (for >48 hours in the previous 2
  • weeks) or who resided in long-term care facilities
  • 3) Patients with a colostomy
  • 4) Patient is enrolled in an interventional clinical study of an anti-infective
  • or immunomodulatory therapy

Investigators

Similar Trials